clinical trial · NCT07035457
A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together
Boehringer Ingelheim·phase1·completed·n = 15
HealthyVicadrostatJardiance®
brief summary
The main objective of this trial is to investigate the relative bioavailability of vicadrostat and empagliflozin when administered in combination or individually.
started
Jul 2, 2025
primary completion
Aug 7, 2025
completion
Aug 15, 2025
last updated
Aug 20, 2025
official title
Relative Bioavailability of Single Doses of Vicadrostat and Empagliflozin Administered Alone Compared to Combined Administration to Healthy Male Subjects (an Open Label, Randomised, Three-way Crossover Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol